News For Placebo


How Cannabis Ingredient CBD Could Help Tackle the Opioid Crisis - Newsweek

How Cannabis Ingredient CBD Could Help Tackle the Opioid Crisis  Newsweek

Scientists hope an ingredient found in cannabis could one day be used to treat people addicted to heroin and in turn help tackle the opioid crisis.

Google 5/21/2019 4:20:02 AM

Pfizer Nabs Regulatory Approval For Tafamidis, An FDA First Is Achieved - Seeking Alpha

Pfizer Nabs Regulatory Approval For Tafamidis, An FDA First Is Achieved  Seeking Alpha

Pfizer obtained FDA approval for drugs Vyndaqel and Vyndamax to treat patients with transthyretin amyloid cardiomyopathy. Vyndaqel and Vyndamax are the ...

Google 5/20/2019 9:58:00 PM

Golimumab reduces PsA signs, symptoms through one year - Healio

Golimumab reduces PsA signs, symptoms through one year  Healio

Intravenous golimumab, in doses of 2 mg per kg, reduced the signs and symptoms of psoriatic arthritis through1 year, with improvements in health-related quality ...

Google 5/20/2019 8:58:50 PM

Nintedanib slows loss of pulmonary function in systemic sclerosis-associated interstitial lung disease - Healio

Nintedanib slows loss of pulmonary function in systemic sclerosis-associated interstitial lung disease  Healio

DALLAS — Patients with interstitial lung disease associated with systemic sclerosis treated with the tyrosine kinase inhibitor nintedanib exhibited a 44% ...

Google 5/20/2019 8:37:28 PM

Clovis Oncology Presents Patient-Centered Outcomes Data from Phase 3 ARIEL3 Study for Rubraca®▼ in Advanced Ovarian Cancer - Yahoo Finance

Clovis Oncology Presents Patient-Centered Outcomes Data from Phase 3 ARIEL3 Study for Rubraca®▼ in Advanced Ovarian Cancer  Yahoo Finance

Quality-adjusted progression free survival and quality-adjusted time without cancer related symptoms or toxicity demonstrate the benefit of Rubraca ...

Google 5/20/2019 8:05:00 PM

Ocular Therapeutix™ Announces Topline Results of Phase 3 Clinical Trial of OTX-TP for the Treatment of Glaucoma - Yahoo Finance

Ocular Therapeutix™ Announces Topline Results of Phase 3 Clinical Trial of OTX-TP for the Treatment of Glaucoma  Yahoo Finance

OTX-TP failed to meet primary endpoint but achieved statistically significant reduction of intraocular pressure versus placebo at eight of the nine pre-specified ...

Google 5/20/2019 8:05:00 PM

Dupilumab Improves Upper, Lower Airway Outcomes in SINUS Trials - MD Magazine

Dupilumab Improves Upper, Lower Airway Outcomes in SINUS Trials  MD Magazine

Among patients in SINUS-24 and SINUS-52 with chronic rhinosinusitis with nasal polyps and comorbid asthma, dupilumab significantly improved function and ...

Google 5/20/2019 7:17:00 PM

Another Antiangiogenic Failure in Unresectable Mesothelioma - MedPage Today

Another Antiangiogenic Failure in Unresectable Mesothelioma  MedPage Today

The addition of nintedanib (Ofev) to standard of care pemetrexed (Alimta) plus cisplatin failed to delay disease progression in patients with unresectable ...

Google 5/20/2019 7:00:00 PM

 1 2 3 4 5  ...